Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias
Authors not listed
Val Lowe · 2021
Abstract
This study is being done to research the usefulness of PET/CT imaging for measuring brain inflammation and its relation to Alzheimer's Disease Dementia and related dementias. Additionally, researchers are looking to learn more about the side effects of a new radioactive tracer (radiotracer) C-11 ER176.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-07 MST
Cite this
APA
Anonymous. (2021). Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias. <em>Val Lowe</em>. https://clinicaltrials.gov/study/NCT04786223
Vancouver
Anonymous. Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias. Val Lowe. 2021.
BibTeX
@misc{anon2021Target,
title = {Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias},
author = {Anonymous},
journal = {Val Lowe},
year = {2021},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cell Death and Differentiation 2008
Citation only
Astroglia in dementia and Alzheimer's disease
Nature reviews. Immunology 2024
Preprint · OA
Neuroinflammation in Alzheimer disease
The Lancet Neurology 2015
Preprint · OA
Neuroinflammation in Alzheimer's disease
The Lancet 2021
Preprint · OA
Alzheimer's disease
Handbook of clinical neurology 2019
Citation only
Alzheimer's disease
Huashan Hospital 2023
Open access · US-GOV